ZEOX — Zeo Scientifix Income Statement
0.000.00%
Last trade - 00:00- $13.04m
- $13.54m
- $4.62m
- 30
- 24
- 27
- 15
Annual income statement for Zeo Scientifix, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | R2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.06 | 5.6 | 6.49 | 4.56 | 4.62 |
| Cost of Revenue | |||||
| Gross Profit | 2.66 | 5.05 | 5.74 | 4.05 | 3.78 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 15.5 | 18.3 | 15.2 | 11.4 | 9.98 |
| Operating Profit | -12.4 | -12.7 | -8.72 | -6.87 | -5.36 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -12.6 | -12.8 | -8.9 | -6.99 | -4.71 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -12.6 | -12.8 | -8.9 | -6.99 | -4.71 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -12.6 | -12.8 | -8.9 | -6.99 | -4.71 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12.6 | -12.8 | -8.9 | -6.99 | -4.71 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.75 | -2.41 | -1.59 | -1.03 | -0.735 |